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Executive Summary 
With rising healthcare costs and increasing demands placed on healthcare workers, it is 
no wonder that decreasing hospital length of stay for patients is high priority for hospitals today. 
Hospital acquired infections are one of the culprits keeping so many patients hospitalized. 
Specifically, in intensive care units (ICU) and intermediate care (IMC) units that care for 
mechanically ventilated patients, ventilator associated pneumonia secondary to intubation is a 
complication and cost that is being sought to be avoided.  Hospitals have been pro-active to 
prevent ventilator associated pneumonia from occurring by placing oral care bundles or protocols 
in place to care for mechanically ventilated patients.  With the recent development of the SARS-
CoV-2 pandemic, it is a reminder of how vital oral care bundles are to prevent pneumonia.  But 
what is the best practice?  Therefore, research had to be done to answer this PICOT question: In 
mechanically ventilated patients (P), how does routinely scheduled oral care with chlorhexidine 
(I) compared to other oral care substances, inconsistent, or no oral care (C) affect ventilator 
associated pneumonia (VAP) (O) within hospitalization stay (T)? 
Rationale 
According to Villar et al. (2016) “VAP is the second most common nosocomial infection in 
ICUs and the first most common in patients receiving mechanical ventilation.” (p. 1245).  
Furthermore, it is estimated that 300,000 patients in the United States are mechanically 
ventilated each year, with up to twenty percent of patients developing VAP (Enwere, Elofson, 
Forbes, & Gerlach, 2016).  Any nurse caring for patients in this patient population group 
understands the additional cost, length of stay, and overall harm that can occur to the patient as a 
result of VAP.  It is evident that VAP is indeed a critical issue for not only hospitals, but more 
importantly, the patients themselves facing this complication.  Therefore, research has been done 
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to discover the best way to prevent VAP.  Specifically, oral care with chlorhexidine has been 
studied as a VAP preventative. Chlorhexidine has gained significant attention, and most agree 
that it is the best source to prevent VAP.  Nurses today that are caring for a mechanically 
ventilated patient will be familiar with that hospital’s protocol of performing oral care with 
chlorhexidine.  However, there are discrepancies about what the best chlorhexidine dose, 
frequency, or application technique is (Villar et al., 2016).  Furthermore, there are discrepancies 
and conflicting research about chlorhexidine really being a significant agent in preventing VAP 
(Villar et al., 2016). 
Literature Synthesis 
According to the systematic review and meta-analysis by Villar et al. (2016) it was 
concluded that chlorhexidine is effective in preventing VAP if using 2% chlorhexidine or 
administering chlorhexidine oral care four times a day (Villar et al., 2016, p. 1258).  The 
information that led to this conclusion was based on 13 studies, included data on 1,640 subjects 
who were randomly allocated to chlorhexidine (n 834) or control (n 806) treatments (Villar et al., 
2016).  However, it was noted that 2% chlorhexidine caused irritation to the oral mucosa in some 
patients.  The effects were reversible, but still, the researchers cautioned against using 2% 
chlorhexidine. It was also noted that 2% chlorhexidine is not usually available for typical 
hospital consumption (Villar et al., 2016).  If anything, this research revealed one of the most 
vital components to preventing VAP- that consistent oral care, performed four times a day, is the 
key to preventing this infection associated with mechanical ventilation.  
Similarly, another study was performed by Özçaka et al., (2012), researching the benefits 
of preventing VAP with 0.2% chlorhexidine gluconate.  This randomized, double-blind, 
controlled study consisted of a sample size of sixty-one patients that were scheduled for invasive 
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mechanical ventilation for at least forty-eight hours.  Thirty-two patients made up the control 
group, while twenty-nine patients made up the intervention group receiving oral care with 0.2% 
chlorhexidine gluconate swabs four times a day.  The aim of the study was to determine if using 
0.2% chlorhexidine gluconate would decrease the incidence of VAP.  Indeed, this question was 
answered by the evidence.  “The VAP development rate was significantly higher in the control 
group than in the CHX group (68.8% vs. 41.4%, respectively; p = 0.03) with an odds ratio of 
3.12 (95% confidence interval = 1.09–8.91)” (Özçaka et al., 2012, p. 584).  Thus, it was 
determined that 0.2% chlorhexidine gluconate oral care performed four times a day with an oral 
swab, should be recommended to ICU’s for the prevention of VAP in ventilated patients (Özçaka 
et al., 2012). 
Further research in regard to using 0.2% chlorhexidine was performed by Chacko et al. 
(2017).  The study was undertaken in a 24-bed medical ICU of a 2,600 bed, tertiary care center 
in South India. Patients were included in the study from January 14, 2014 to December 27, 2014.  
There were 206 eligible subjects; 104 patients in the experimental group and 102 patients in the 
control group (Chako et al., 2017).  One of the purposes of this double-blind, randomized control 
trial was to see if a new technique of brushing a ventilated patient’s teeth with chlorhexidine 
0.2% and suctioning three times a day (with a disposable Yankauer suction catheter) was 
superior to regular oral care protocols consisting of only swabbing the mouth with chlorhexidine 
0.2% three times a day (Chacko et al., 2017).  Since this study considered a p-value less than 
0.05 to be statistically significant, a p-value of 0.82 representing the VAP significance between 
both groups concluded that there was no significant difference between the two oral care 
protocols (Chacko et al., 2017).  Thus, in the end, this study concluded that tooth-brushing with 
chlorhexidine 0.2% is not superior to simply swabbing the oral cavity with a swab soaked in 
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chlorhexidine 0.2%.  But the researchers concluded that meticulous and consistent oral care is 
key to preventing VAP and that nurses must be taught the importance of complying with oral 
care bundles established in hospitals (Chacko et al., 2017).   
 Another article was examined to determine if chlorhexidine really is beneficial in preventing 
VAP.  This time, not only chlorhexidine and tooth-brushing were evaluated, but mechanical 
tooth-brushing was examined as well.  According to the research of Munro, Grap, Jones, 
McClish, and Sessler (2009), the purpose of their study was to examine the effects of mechanical 
(tooth-brushing), pharmacological (topical oral chlorhexidine), and combination (tooth-brushing 
plus chlorhexidine) oral care on the development of ventilator-associated pneumonia (VAP) in 
critically ill patients receiving mechanical ventilation (Munro et al., 2009).  This randomized 
clinical control trial with a 2x2 factorial design screened 10,910 patients.  A total of 1,416 
patients met the study criteria, 547 patients ultimately gave consent to participate in the study, 
and those patients were assigned to randomized group assignments for the study.  Patients were 
randomly assigned to one of four treatments: a 0.12% solution of chlorhexidine gluconate 5ml by 
oral swab twice a day, tooth-brushing three times a day, a combination of both stated treatments 
of tooth-brushing three times a day and 0.12% chlorhexidine gluconate every 12 hours, or a 
control group that received usual care (Munro et al., 2009).  The VAP diagnosis was scored by 
using the Clinical Pulmonary Infection Score (CPIS).  It was found that 0.12% chlorhexidine 
significantly reduced the incidence of pneumonia on day 3 (CPIS ≥6) among patients who had 
CPIS <6 at baseline (P=.006).  Furthermore, it was found that tooth-brushing had no effect on 
CPIS and did not enhance the effect of chlorhexidine.  It should also be noted that 0.12% 
chlorhexidine gluconate was used because the Food and Drug Administration approves of this 
chlorhexidine strength in the United States (Munro et al., 2009).  
VENTILATOR ASSOCIATED PNEUMONIA  8 
 Thus far chlorhexidine oral care has been examined as a means of performing oral care to 
prevent VAP.  But other substances should be examined before determining that chlorhexidine 
is the best oral care substance.  A systematic review, “Oral Hygiene Care for Critically Ill 
Patients to Prevent Ventilator Associated Pneumonia,” (Shi et al., 2013), examined thirty-five 
randomized control trials.  These thirty-five trials consisted of 5,374 critically ill patients 
randomly assigned to interventions.  The interventions were grouped into four categories to 
examine different oral care substances and methods: Chlorhexidine mouth-rinse or gel 
compared to placebo with or without toothbrushing, toothbrushing compared with no 
toothbrushing, powered toothbrushing compared with manual, and oral care with other 
substances (saline, bicarbonate, povidone iodine, and triclosan).  All studies took place in ICU 
units in hospitals. Patients were categorized as either medical, surgical, or trauma patients, 
although thirteen studies did not specify patients according to these categories.  Amidst the wide 
variety of patients, it was determined that there was weak evidence that povidone iodine rinse 
was more effective than saline at preventing VAP (OR 0.35, 95% CI 0.19 to 0.65, p = 0.0009, 
I2 = 53%) however there was moderate evidence for the use of chlorhexidine (either as a 
mouth-rinse or gel) to decrease the odds of a patient developing VAP with an OR of 0.60, 95% 
CI 0.47 to 0.77, p< 0.001, I2 = 21%, and a NNT of 15 (95% CI 10 to 34) according to Shi et al., 
(2013).  It is also worthy to note that no difference was noted in VAP incidence when 
chlorhexidine oral care was compared to tooth-brushing with chlorhexidine (Shi et al., 2013) 
 Finally, amidst the previous systematic reviews and randomized clinical control trials 
stated above, it is appropriate to examine a retrospective cohort study to see how implementing a 
chlorhexidine mouthwash bundle in an ICU affected the incidence of VAP.  According to 
“Impact of Chlorhexidine Mouthwash Prophylaxis on Probable Ventilator-Associated 
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Pneumonia in a Surgical Intensive Care Unit” (Enwere et al., 2016), the study took place in a 
forty-bed surgical ICU.  Patients were evaluated prior to chlorhexidine mouthwash intervention 
from January 1, 2009 to December 31, 2009.  Patients were that evaluated post-chlorhexidine 
implementation from March 1, 2010 to February 28, 2011.  In total, 1,780 mechanically 
ventilated patients were evaluated for inclusions to comprise the pre-chlorhexidine group, while 
1,854 mechanically ventilated patients were evaluated to make up the post-chlorhexidine group. 
In the end, 601 patients ultimately met criteria to be included for evaluation to equal ninety-four 
patients in the pre-chlorhexidine group, and sixty-four patients in the post-chlorhexidine group.  
It was noted between the two groups that VAP rate was significantly decreased in the post-
chlorhexidine group compared to the pre-chlorhexidine group, (1.85% pre vs 0.81% post, p = 
0.0082) according to Enwere et al., (2016). 
Stakeholders 
Any nurse caring for patients in this patient population group understands the additional 
cost, length of stay, and overall harm that can occur to the patient as a result of VAP. With a 9-
27% risk of contracting VAP after being intubated and a 25-50% mortality risk once VAP is 
contracted, it is evident that VAP is indeed a critical issue for not only hospitals, but more 
importantly, the patients themselves facing this complication (Efrati et. al, 2010).  Therefore, 
research has been done to discover the best way to prevent VAP.  Chlorhexidine has gained 
significant attention and is known for outstanding prevention of VAP.  Nurses today that are 
caring for a mechanically ventilated patient will be familiar with that hospital’s protocol of 
performing oral care with chlorhexidine.  Despite the nurse’s busy schedule of working in an 
ICU or an IMC unit, it is important to not underestimate the role they play in preventing their 
patient from developing VAP.  Patients and their family members in this population highly value 
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being able to go home as soon as possible.  Nurses can make this possible by preventing 
complications such as VAP by administering oral care with chlorhexidine.  
The major factor that is undeniable in ensuring that this project is implemented is the 
amount of cost that will be saved by the hospital. It is estimated that VAP costs an additional 
total of $40,000 to a hospital stay (Efrati et. al, 2010).  With a 9-27% risk of VAP occurring after 
intubation as was stated earlier, this is a significant cost that the hospital could save, not to 
mention patients’ lives (Efrati et. al, 2010). 
Implementation 
In the twenty-first century nurses are being required to perform more and more tasks for 
their patients- and also for the hospital.  Depending on the day and how busy it is, certain tasks 
will have to get over-looked or not successfully completed by the nurse. One such task may be 
oral care for ventilated patients.  Sure, it may get completed once a shift or so, but consistency is 
key to preventing VAP (Enwere et al., 2016). 
The suggested implementation to prevent VAP per evidence-based practice is:  
1. Use chlorhexidine 0.2% liquid. 
2. Apply chlorhexidine 0.2% with oral swab as opposed to using a toothbrush. 
3. Apply two times a day. 
Therefore, the greatest challenge to implementation is ensuring that nurses will perform oral care 
consistently, twice a day, or two times per a twelve-hour shift.  A suggestion to help remind 
nurses to perform oral care for their patients would be to have a section for nurses to scan in the 
electronic medical record. Just as other medications need to be scanned before the nurse gives 
them to the patient, so should the chlorhexidine container and mouth swab be required to have a 
barcode on it so that the nurse must scan the objects in order to be compliant with caring for the 
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patient.  It has been shown that once nurses are compliant in performing oral care, that 



















Data Collection Methods 
 First of all, nurses are vital in implementing this project. Nurses on the designated unit 
that will be caring for mechanically ventilated patients should be educated on the protocol that 
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liquid. 
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0.2% with oral swab 
• Apply two times a day. 
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liquid. 
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0.2% with oral swab 
• Apply two times a day. 
(Q 6 hours) 
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type of patient such as trauma, neuro, or cardiac, so as to avoid variables.  A retrospective study 
should be completed to evaluate the VAP incidence rate among patients in that ICU for the same 
time period the year before.  Then, a consent form should be signed by the guardian or power of 
attorney of the patient to give consent for the trial of the evidence based VAP prevention 
protocol. Of course, the trial should be optional for patients. The trial should take place over five 
months to ensure adequate data collection from enough patients. The following administration of 
oral care using chlorhexidine for ventilated patients should be as follows: 
1. Use chlorhexidine 0.2% liquid. 
2. Apply chlorhexidine 0.2% with oral swab as opposed to using a toothbrush. 
3. Apply two times a day (twice a twelve-hour shift). 
A VAP prevention coordinator should be assigned to the study and should monitor how many 
patients develop VAP. The criteria that should be assessed in each patient is fever, tachycardia, 
oxygen saturation, x-ray and CT imaging noting pneumonia per the radiologist’s reading.  
Cost/Benefit Discussion 
As mentioned earlier, it is estimated that VAP costs an additional total of $40,000 to a 
hospital stay (Efrati et. al, 2010). Furthermore, a peer reviewed study completed by AACN found 
that not only does VAP prevention increase the lifespan of an elderly patient by 10.84 years of 
life but can also reduce the cost of care by up to $150,000 (AACN, 2015). With a 9-27% risk of 
contracting VAP and a 25-50% mortality risk once VAP is contracted, it is obvious that 
successfully preventing VAP is a worthwhile endeavor for a hospital (Efrati et. al, 2010).  
Undoubtedly, VAP prevention is not only for the patient’s benefit, but also cost saving for the 
hospital.  
Overall Discussions/Results 
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 After reviewing the oral care interventions that support VAP incidence decrease for 
mechanically ventilated patients, it is appropriate to propose a VAP bundle based upon the 
evidence examined. First, chlorhexidine 0.2% should be used. Three out of the six articles 
studied included evidence of chlorhexidine 0.2% preventing VAP incidence. It was noted that 
2% chlorhexidine can cause irritation to the oral mucosa and is not typically available for 
hospital consumption (Villar et al., 2016), so 2% chlorhexidine should not be recommended. 
Second, chlorhexidine 0.2% should be applied with an oral swab as opposed to a toothbrush 
since there is little to no evidence that tooth-brushing provides any better VAP prevention than 
using a plain swab according to Shi et al., (2013) and Munro et al., (2009).  Finally, 
chlorhexidine oral care should be performed twice a day due to the evidence that Enwere et al., 
(2016), Munro et al., (2009), Özçaka et al., (2012), Shi et al., (2013) provided.  Thus, the 
preliminary plan to implement change and decrease VAP incidence in ICUs for mechanically 
ventilated patients can be summarized as: 
1. Use chlorhexidine 0.2% liquid. 
2. Apply chlorhexidine 0.2% with oral swab as opposed to using a toothbrush. 
3. Apply two times a day (twice during a 12-hour shift). 
Recommendations 
Nurses are vital to this protocol being a success.  In order for lives to be saved, length of 
stay to be decreased, and for money to be saved by the hospital, the hospital needs to help their 
nurses with this protocol.  Throughout the implementation process open communication needs to 
be available between the nurses and their managers.  Undoubtedly, issues and complications may 
arise.  But in order for this protocol to be a success, nurses need to be empowered to bring issues 
to their manager, coordinator, and even the CEO of the hospital.  As was mentioned earlier, the 
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study by Hui, Kit, & Poh (2016) assessed the implementation of VAP protocols by nurses. It was 
found that when the nurses were given an audit, feedback, and re-audit strategy, that VAP 
incidence decreased by 64% (Hui, Kit, & Poh, 2016). During the audit period prior to feedback, 
it was discovered that nurses were participating in different aspects of the VAP bundle from 0%-
47%. After this feedback was given to the nurses, an increase in actually performing essential 
tasks of the VAP bundle increased from 50%-90%. Which as previously stated, resulted in a 
64% decrease in VAP incidence (Hui, Kit, & Poh, 2016). Just as this study showed, it is 
important for nurses to receive feedback and recognition for the work they are doing so that they 
know a task in not just extra work- but is an essential and life-saving portion of their job. Nurses 
are key not only to saving the lives of patients, but also to saving the hospital money.  
Conclusion 
As the above articles and evidence has indicated, chlorhexidine is indeed effective in 
preventing VAP in mechanically ventilated adult patients. The key to making this proposed VAP 
bundle effective, however, is consistency.  With nurses being responsible for more and more 
patients and tasks as the years go by, it is easy for a nurse to overlook tasks that do not seem as 
vital to helping the patient thrive.  Therefore, this information is valuable to pass on to today’s 
nurses.  Education should be conveyed so that nurses realize the critical value of oral care, and 
do not just skip the task or provide it inconsistently.  The importance of preventative care for 
patients at risk for VAP cannot be summed up any better than this phrase: “Risk of VAP starts 
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Appendix A: Synthesis/Outcomes Table 
Table 1: Interventions 
Interventions: A B C D E F 
2% CH QID      X 
0.2% CH X      
0.12% BID   X    
0.2%CH BID    X   
Na+    X   
TB w/0.12%CH   X    
TB w/0.2% CH X      
Manual TB   X  X  
Powered TB     X  
0.12% CH 
mouthwash BID 
 X   X  
CH Gel     X  
A=Chacko et al. (2017); B= Enwere et al. (2016); C= Munro et al. (2009); D= Özçaka et al. 
(2012); E= Shi et al. (2013); F= Villar et al. (2016). 
 
X= indication that intervention was used in study.  
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Appendix A: Continued 
Table 2: Design, Sample, Outcomes 
Studies 
Evaluating the 
Effects of CH: 
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D RCT,  
double blind study 
N=61    
E Meta-analysis N=5,374 
 
 S S 






 NM NM 
A=Chacko et al. (2017); B= Enwere et al. (2016); C= Munro et al. (2009); D= Özçaka et al. 
(2012); E= Shi et al. (2013); F= Villar et al. (2016). 
 
   = decrease  
   = increase  
LOS= length of stay in ICU 
N= number of patients in the sample studied 
NA= not applicable 
NM= not mentioned 
S= similar, the same, or little difference 
 
   
   
   
   
   
   
      
   
   
   
   
